Scholarlink

Background <p> Opioids such as morphine and fentanyl are widely used for pain management and in cardiovascular conditions; however, their misuse has become a significant public health concern. Non-cardiogenic pulmonary edema is a hallmark of opioid intoxication, often associated with impaired alveolar fluid clearance (AFC), a sodium transport–driven process that removes excess fluid from the alveoli.</p> Aims <p> This study aimed to elucidate the potential mechanisms of morphine-induced pulmonary edema by investigating the effects of μ-, δ-, and κ-opioid receptor (MOR, DOR, and KOR) modulation on AFC in rat lungs and determining whether receptor-specific blockade alters sodium transport across the alveolar epithelium.</p> Methods <p> Adult male Wistar rats were anesthetized, and a 5% BSA solution was instilled intratracheally to quantify alveolar fluid clearance (AFC) using bronchoalveolar lavage (BAL). A dose–response analysis (0.1–10 µM morphine) identified 10 µM as the concentration that significantly impaired AFC. Immunohistochemistry was performed to identify MOR, DOR, and KOR localization in lung tissue. To assess receptor-specific involvement, rats received intratracheal co-administration of morphine with selective antagonists (10 µM)—β-Funaltrexamine (μ), Naltrindole (δ), or Nor-binaltorphimine (κ)—and/or the ENaC inhibitor amiloride (1 mM).</p> Results <p> All receptor subtypes were expressed in type II alveolar cells and macrophages. Morphine (10 µM) reduced AFC significantly. DOR antagonism produced the most marked impairment, whereas μ- and κ-blockade caused ENaC-dependent reductions comparable to amiloride.</p> Conclusions <p> Opioid-induced AFC impairment involves receptor-specific alterations in alveolar fluid regulation, with the DOR playing a dominant inhibitory role, suggesting its involvement in the development of pulmonary edema.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mechanistic insights into opioid-induced pulmonary edema: receptor specificity and sodium transport

  • 期刊论文

  • 发表日期：

    2025年12月12日

查看全文
  • Şevin Güney,
  • Hatice Betül Moğulkoç,
  • Saadet Özen Akarca Dizakar,
  • Gülnur Take Kaplanoğlu

摘要

Background

Opioids such as morphine and fentanyl are widely used for pain management and in cardiovascular conditions; however, their misuse has become a significant public health concern. Non-cardiogenic pulmonary edema is a hallmark of opioid intoxication, often associated with impaired alveolar fluid clearance (AFC), a sodium transport–driven process that removes excess fluid from the alveoli.

Aims

This study aimed to elucidate the potential mechanisms of morphine-induced pulmonary edema by investigating the effects of μ-, δ-, and κ-opioid receptor (MOR, DOR, and KOR) modulation on AFC in rat lungs and determining whether receptor-specific blockade alters sodium transport across the alveolar epithelium.

Methods

Adult male Wistar rats were anesthetized, and a 5% BSA solution was instilled intratracheally to quantify alveolar fluid clearance (AFC) using bronchoalveolar lavage (BAL). A dose–response analysis (0.1–10 µM morphine) identified 10 µM as the concentration that significantly impaired AFC. Immunohistochemistry was performed to identify MOR, DOR, and KOR localization in lung tissue. To assess receptor-specific involvement, rats received intratracheal co-administration of morphine with selective antagonists (10 µM)—β-Funaltrexamine (μ), Naltrindole (δ), or Nor-binaltorphimine (κ)—and/or the ENaC inhibitor amiloride (1 mM).

Results

All receptor subtypes were expressed in type II alveolar cells and macrophages. Morphine (10 µM) reduced AFC significantly. DOR antagonism produced the most marked impairment, whereas μ- and κ-blockade caused ENaC-dependent reductions comparable to amiloride.

Conclusions

Opioid-induced AFC impairment involves receptor-specific alterations in alveolar fluid regulation, with the DOR playing a dominant inhibitory role, suggesting its involvement in the development of pulmonary edema.